Efficacy and Safety of Darusentan in Patients With Resistant Hypertension: Results From a Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study-Reference-Cited by-同舟云学术

Efficacy and Safety of Darusentan in Patients With Resistant Hypertension: Results From a Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study

Published:2007-10 Issue:10 Volume:9 Page:760-769
ISSN:1524-6175
Container-title:The Journal of Clinical Hypertension
language:en
Short-container-title:

Author:

Black Henry R.,Bakris George L.,Weber Michael A.,Weiss Robert,Shahawy Mahfouz El,Marple Richard,Tannoury Georges,Linas Stuart,Wiens Brian L.,Linseman Jennifer V.,Roden Robert,Gerber Michael J.

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1524-6175.2007.07244.x/fullpdf

Reference30 articles.

1. Global burden of hypertension: analysis of worldwide data;Kearney;Lancet,2005

2. Clinical Advisory Statement. Importance of systolic blood pressure in older Americans;Izzo;Hypertension,2000

3. Calcium channel blockers in the treatment of hypertension and prevention of cardiovascular disease: results from major clinical trials;Black;Clin Cornerstone,2004

4. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure;Hypertension,2003

5. Ambulatory blood pressure monitoring and clinical characteristics of the true and white-coat resistant hypertension;Veglio;Clin Exp Hypertens,2001

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Initial real-world experience of clazosentan for subarachnoid hemorrhage in Japan;World Neurosurgery: X;2024-01

2. Efficacy of pharmacological and interventional treatment for resistant hypertension: a network meta-analysis;Cardiovascular Research;2023-10-27

3. New Therapy Update Aprocitentan: An Endothelin Receptor Antagonist for the Treatment of Drug-Resistant Systemic Hypertension;Cardiology in Review;2023-08-02

4. A systematic review and meta-analysis of all sham and placebo controlled trials for resistant hypertension;European Journal of Internal Medicine;2023-07

5. Efficacy of pharmacological and interventional treatment for resistant hypertension-a network meta-analysis;2023-04-24